THE INTERACTION BETWEEN INSTITUTIONAL ENVIRONMENT AND INNOVATIVE ENTREPRENEURSHIP IN UKRAINE

Por I. Prylutska
Publicado em 2014-09-01

Biological determinants of physical activity differentiation for women of the first mature age (aged 21 to 35) who do water fitness

Por Anna Tkachova, Nataliia Goncharova, Tetyana Prylutsʹka
Publicado em 2017-11-01

Contemporary points on monitoring the spatial organization of the human body in the process of physical education

Por Vitaliy Kashuba, Serhii Lopatskyi, Tetyana Prylutska
Publicado em 2017-06-01

A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema

Por Prylutskyi, Oleksander, Prylutska, Olga, Degonskyi, Anatoliy, Tkachenko, Kseniia
Publicado no Ethiop J Health Sci (2016)

HPLC-ESI-MS method for C60 fullerene mitochondrial content quantification

Por Anna Grebinyk, Sergii Grebinyk, Svitlana Prylutska, Uwe Ritter, Olga Matyshevska, Thomas Dandekar, Marcus Frohme
Publicado em 2018-08-01

C(60) Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment

Por Prylutska, Svitlana, Grynyuk, Iryna, Matyshevska, Olga, Prylutskyy, Yuriy, Evstigneev, Maxim, Scharff, Peter, Ritter, Uwe
Publicado no Drugs R D (2014)

HPLC-ESI-MS method for C(60) fullerene mitochondrial content quantification

Por Grebinyk, Anna, Grebinyk, Sergii, Prylutska, Svitlana, Ritter, Uwe, Matyshevska, Olga, Dandekar, Thomas, Frohme, Marcus
Publicado no Data Brief (2018)

Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro

Por Grebinyk, Anna, Prylutska, Svitlana, Grebinyk, Sergii, Prylutskyy, Yuriy, Ritter, Uwe, Matyshevska, Olga, Dandekar, Thomas, Frohme, Marcus
Publicado no Nanoscale Res Lett (2019)

Correction to: Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro

Por Grebinyk, Anna, Prylutska, Svitlana, Grebinyk, Sergii, Prylutskyy, Yuriy, Ritter, Uwe, Matyshevska, Olga, Dandekar, Thomas, Frohme, Marcus
Publicado no Nanoscale Res Lett (2019)

Fullerene C(60) Penetration into Leukemic Cells and Its Photoinduced Cytotoxic Effects

Por Franskevych, D., Palyvoda, K., Petukhov, D., Prylutska, S., Grynyuk, I., Schuetze, C., Drobot, L., Matyshevska, O., Ritter, U.
Publicado no Nanoscale Res Lett (2017)

Regional recaptures of bats (Chiroptera, Vespertilionidae) ringed in Eastern Ukraine

Por A. Vlaschenko, A. Prylutska, K. Kravchenko, O. Rodenko, V. Hukov, O. Timofieieva, O. Holovchenko, M. Moiseienko, V. Kovalov
Publicado em 2020-02-01

Using water-soluble C(60) fullerenes in anticancer therapy

Por Prylutska, S. V., Burlaka, A. P., Klymenko, P. P., Grynyuk, I. I., Prylutskyy, Yu. I., Schütze, Ch., Ritter, U.
Publicado no Cancer Nanotechnol (2011)

Analysis of Biomechanical and Biochemical Markers of Rat <i>Muscle Soleus</i> Fatigue Processes Development during Long-Term Use of C₆₀ Fullerene and N-Acetylcysteine

Por Dmytro Nozdrenko, Svitlana Prylutska, Kateryna Bogutska, Vsevolod Cherepanov, Anton Senenko, Oksana Vygovska, Sergii Khrapatyi, Uwe Ritter, Yuriy Prylutskyy, Jacek Piosik
Publicado em 2022-05-01

In vitro study of the anticancer activity of various doxorubicin-containing dispersions

Por Matvienko, Tatiana, Sokolova, Viktoriya, Prylutska, Svitlana, Harahuts, Yuliia, Kutsevol, Nataliya, Kostjukov, Viktor, Evstigneev, Maxim, Prylutskyy, Yuriy, Epple, Matthias, Ritter, Uwe
Publicado no Bioimpacts (2019)

Synergy of Chemo- and Photodynamic Therapies with C₆₀ Fullerene-Doxorubicin Nanocomplex

Por Anna Grebinyk, Svitlana Prylutska, Oksana Chepurna, Sergii Grebinyk, Yuriy Prylutskyy, Uwe Ritter, Tymish Y. Ohulchanskyy, Olga Matyshevska, Thomas Dandekar, Marcus Frohme
Publicado em 2019-10-01

Cytotoxic Effects of Dimorfolido-N-Trichloroacetylphosphorylamide and Dimorfolido-N-Benzoylphosphorylamide in Combination with C(60) Fullerene on Leukemic Cells and Docking Study o...

Por Prylutska, S., Grynyuk, I., Grebinyk, A., Hurmach, V., Shatrava, Iu., Sliva, T., Amirkhanov, V., Prylutskyy, Yu., Matyshevska, O., Slobodyanik, M., Frohme, M., Ritter, U.
Publicado no Nanoscale Res Lett (2017)

A nanocomplex of C(60) fullerene with cisplatin: design, characterization and toxicity

Por Prylutska, Svitlana, Politenkova, Svitlana, Afanasieva, Kateryna, Korolovych, Volodymyr, Bogutska, Kateryna, Sivolob, Andriy, Skivka, Larysa, Evstigneev, Maxim, Kostjukov, Viktor, Prylutskyy, Yuriy, Ritter, Uwe
Publicado no Beilstein J Nanotechnol (2017)

C(60) Fullerene Effects on Diphenyl-N-(trichloroacetyl)-amidophosphate Interaction with DNA In Silico and Its Cytotoxic Activity Against Human Leukemic Cell Line In Vitro

Por Grebinyk, A., Prylutska, S., Grynyuk, I., Kolp, B., Hurmach, V., Sliva, T., Amirkhanov, V., Trush, V., Matyshevska, O., Slobodyanik, M., Prylutskyy, Yu., Frohme, M., Ritter, U.
Publicado no Nanoscale Res Lett (2018)

C60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes

Por Larysa M. Skivka, Svitlana V. Prylutska, Mariia P. Rudyk, Nataliia M. Khranovska, Ievgeniia V. Opeida, Vasyl V. Hurmach, Yuriy I. Prylutskyy, Leonid F. Sukhodub, Uwe Ritter
Publicado em 2018-10-01

C(60) fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes

Por Skivka, Larysa M., Prylutska, Svitlana V., Rudyk, Mariia P., Khranovska, Nataliia M., Opeida, Ievgeniia V., Hurmach, Vasyl V., Prylutskyy, Yuriy I., Sukhodub, Leonid F., Ritter, Uwe
Publicado no Cancer Nanotechnol (2018)